CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.39−0.96 (-1.95%)
Close on Nov 17, 2026Market cap $1.44BP/E 20.0Yield 1.24%
Conmed cash
Cash and short-term investments held at the end of each period.
Conmed's cash was $47.97M at Sep 30, 2026. For fiscal 2025 it was $40.82M, up 66.9% from the year before. Over ten years it grew -5.6% a year on average. The highest annual figure on record is $72.50M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.82M | +66.9% |
| FY2024 | Dec 31, 2024 | $24.46M | +0.7% |
| FY2023 | Dec 31, 2023 | $24.30M | -16.1% |
| FY2022 | Dec 31, 2022 | $28.94M | +38.8% |
| FY2021 | Dec 31, 2021 | $20.85M | -23.8% |
| FY2020 | Dec 31, 2020 | $27.36M | +5.8% |
| FY2019 | Dec 31, 2019 | $25.86M | +47.7% |
| FY2018 | Dec 31, 2018 | $17.51M | -46.3% |
| FY2017 | Dec 31, 2017 | $32.62M | +18.9% |
| FY2016 | Dec 31, 2016 | $27.43M | -62.2% |
| FY2015 | Dec 31, 2015 | $72.50M | +9.3% |
| FY2014 | Dec 31, 2014 | $66.33M | +21.8% |
| FY2013 | Dec 31, 2013 | $54.44M | +129.5% |
| FY2012 | Dec 31, 2012 | $23.72M | -8.9% |
| FY2011 | Dec 31, 2011 | $26.05M | +109.8% |
| FY2010 | Dec 31, 2010 | $12.42M | +23.0% |
| FY2009 | Dec 31, 2009 | $10.10M | -14.5% |
| FY2008 | Dec 31, 2008 | $11.81M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $47.97M | +23.2% |
| Q2 FY2026 | Jun 30, 2026 | $37.33M | +10.0% |
| Q1 FY2026 | Mar 31, 2026 | $35.03M | -1.3% |
| Q4 FY2025 | Dec 31, 2025 | $40.82M | +66.9% |
| Q3 FY2025 | Sep 30, 2025 | $38.93M | +1.2% |
| Q2 FY2025 | Jun 30, 2025 | $33.94M | +17.5% |
| Q1 FY2025 | Mar 31, 2025 | $35.49M | +4.8% |
| Q4 FY2024 | Dec 31, 2024 | $24.46M | +0.7% |
| Q3 FY2024 | Sep 30, 2024 | $38.47M | +26.1% |
| Q2 FY2024 | Jun 30, 2024 | $28.87M | +3.7% |
| Q1 FY2024 | Mar 31, 2024 | $33.86M | +27.8% |
| Q4 FY2023 | Dec 31, 2023 | $24.30M | -16.1% |
| Q3 FY2023 | Sep 30, 2023 | $30.50M | -8.6% |
| Q2 FY2023 | Jun 30, 2023 | $27.85M | -47.6% |
| Q1 FY2023 | Mar 31, 2023 | $26.49M | +6.6% |
| Q4 FY2022 | Dec 31, 2022 | $28.94M | +38.8% |
| Q3 FY2022 | Sep 30, 2022 | $33.35M | +5.8% |
| Q2 FY2022 | Jun 30, 2022 | $53.15M | +14.6% |
| Q1 FY2022 | Mar 31, 2022 | $24.86M | -32.4% |
| Q4 FY2021 | Dec 31, 2021 | $20.85M | -23.8% |
| Q3 FY2021 | Sep 30, 2021 | $31.51M | -11.5% |
| Q2 FY2021 | Jun 30, 2021 | $46.39M | +32.6% |
| Q1 FY2021 | Mar 31, 2021 | $36.77M | +51.3% |
| Q4 FY2020 | Dec 31, 2020 | $27.36M | +5.8% |
| Q3 FY2020 | Sep 30, 2020 | $35.60M | +18.4% |
| Q2 FY2020 | Jun 30, 2020 | $34.98M | +55.1% |
| Q1 FY2020 | Mar 31, 2020 | $24.31M | +3.9% |
| Q4 FY2019 | Dec 31, 2019 | $25.86M | +47.7% |
| Q3 FY2019 | Sep 30, 2019 | $30.07M | +1.3% |
| Q2 FY2019 | Jun 30, 2019 | $22.55M | -3.6% |
| Q1 FY2019 | Mar 31, 2019 | $23.41M | +10.8% |
| Q4 FY2018 | Dec 31, 2018 | $17.51M | -46.3% |
| Q3 FY2018 | Sep 30, 2018 | $29.69M | -32.6% |
| Q2 FY2018 | Jun 30, 2018 | $23.40M | -41.7% |
| Q1 FY2018 | Mar 31, 2018 | $21.13M | -39.0% |
| Q4 FY2017 | Dec 31, 2017 | $32.62M | +18.9% |
| Q3 FY2017 | Sep 30, 2017 | $44.03M | – |
| Q2 FY2017 | Jun 30, 2017 | $40.14M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.66M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.43M | – |
See a number that looks wrong?